Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jiph.2021.05.007 http://scihub22266oqcxt.onion/10.1016/j.jiph.2021.05.007 34130119!8153960!34130119     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Infect+Public+Health 2021 ; 14 (7): 954-959 Nephropedia Template TP {{tp|p=34130119|t=2021. The immunological response among COVID-19 patients with acute respiratory distress syndrome |pdf=|usr=}}{{34130119}} gab.com Text The immunological response among COVID-19 patients with acute respiratory distress syndrome JO: J Infect Public Health http://www.kidney.de/pget.php?&tw=1&pmid=34130119 #FOAvip Coronavirus disease 2019 (COVID-19) often results in pneumonia and can lead to acute respiratory distress syndrome (ARDS). ARDS is one of the most significant causes of death in patients with COVID-19. The development of a "cytokine storm" in patients with COVID-19 causes progression to ARDS. In this scoping review, we investigated the effect of pro-inflammatory cytokines in inducing moderate and severe ARDS outcomes. A comprehensive search was performed using PubMed and Google Scholar to implement a broad query that captured all the relevant studies published between December 2019 and September 2020.We identified seven studies that evaluated the immune response in COVID-19 patients with ARDS. The white blood cell counts (WBCs), CRP, and IL-6 were higher in the moderately presenting ARDS patients, critically ill patients, and those with more severe ARDS. This study may contribute to better patient management and outcomes if tailored immune marker interventions are implemented in the near future. Twit Text FOAVip The immunological response among COVID-19 patients with acute respiratory distress syndrome ????J Infect Public Health http://www.kidney.de/pget.php?&tw=1&pmid=34130119 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34130119 #FOAvip English Wikipedia <ref>{{Cite pmid|34130119}}</ref> The immunological response among COVID-19 patients with acute respiratory distress syndrome #MMPMID34130119 Almutairi AS; Abunurah H; Hadi Alanazi A; Alenazi F; Nagy H; Saad Almutairi N; Wells M; Alawam A; Alqahtani MM J Infect Public Health 2021[Jul]; 14 (7): 954-959 PMID34130119show ga Coronavirus disease 2019 (COVID-19) often results in pneumonia and can lead to acute respiratory distress syndrome (ARDS). ARDS is one of the most significant causes of death in patients with COVID-19. The development of a "cytokine storm" in patients with COVID-19 causes progression to ARDS. In this scoping review, we investigated the effect of pro-inflammatory cytokines in inducing moderate and severe ARDS outcomes. A comprehensive search was performed using PubMed and Google Scholar to implement a broad query that captured all the relevant studies published between December 2019 and September 2020.We identified seven studies that evaluated the immune response in COVID-19 patients with ARDS. The white blood cell counts (WBCs), CRP, and IL-6 were higher in the moderately presenting ARDS patients, critically ill patients, and those with more severe ARDS. This study may contribute to better patient management and outcomes if tailored immune marker interventions are implemented in the near future. |*COVID-19[MESH] |*Respiratory Distress Syndrome[MESH] |Cytokine Release Syndrome[MESH] |Cytokines[MESH] |Humans[MESH]The immunological response among COVID-19 patients with acute respirat(epmc).pdf DeepDyve Pubget Overpricing